source
- Patient dies in Bristol Myers Squibb autoimmune CAR-T trial, raising safety concernsBristol Myers Squibb reported that a participant in its Phase 1 CAR-T study for multiple sclerosis died. The trial was testing an investigational CAR-T therapy aimed at autoimmune disease. The pat…
- US Treasury proposes rule that could bar biotech investments in ChinaThe Treasury Department issued a proposed rule to implement the 2025 COINS Act, which governs U.S. investment in sensitive technologies in China and other countries. The proposal places a broad ra…